These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 9593116)

  • 21. Co-trimoxazole versus dapsone-pyrimethamine for prevention of Pneumocystis carinii pneumonia.
    Coker RJ; Nieman R; McBride M; Mitchell DM; Harris JR; Weber JN
    Lancet; 1992 Oct; 340(8827):1099. PubMed ID: 1357487
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current alternatives in the treatment of Pneumocystis carinii pneumonia in patients with AIDS].
    Pastor C; Lumbreras C; Lizasoain M
    Med Clin (Barc); 1994 Oct; 103(12):473-6. PubMed ID: 7996899
    [No Abstract]   [Full Text] [Related]  

  • 23. Pneumocystis carinii pneumonia: therapy and prophylaxis.
    Kovacs JA; Masur H
    J Infect Dis; 1988 Jul; 158(1):254-9. PubMed ID: 2969023
    [No Abstract]   [Full Text] [Related]  

  • 24. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
    El-Sadr WM; Murphy RL; Yurik TM; Luskin-Hawk R; Cheung TW; Balfour HH; Eng R; Hooton TM; Kerkering TM; Schutz M; van der Horst C; Hafner R
    N Engl J Med; 1998 Dec; 339(26):1889-95. PubMed ID: 9862944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dapsone/pyrimethamine versus aerosolized pentamidine as prophylaxis against PCP in HIV infection.
    Dorrell L; McCallum AK; Snow MH; Ong EL
    AIDS Patient Care; 1995 Oct; 9(5):224-8. PubMed ID: 11361401
    [No Abstract]   [Full Text] [Related]  

  • 26. Prophylaxis and therapy for Pneumocystis pneumonia--where are we?
    Masur H
    Infect Agents Dis; 1992 Oct; 1(5):270-8. PubMed ID: 1344666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing PCP therapy.
    Torres G; Cadman J
    GMHC Treat Issues; 1997 Oct; 11(10):3-5. PubMed ID: 11364821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines.
    Goldie SJ; Kaplan JE; Losina E; Weinstein MC; Paltiel AD; Seage GR; Craven DE; Kimmel AD; Zhang H; Cohen CJ; Freedberg KA
    Arch Intern Med; 2002 Apr; 162(8):921-8. PubMed ID: 11966344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the activities of rifabutin combined with atovaquone or low-dose of cotrimoxazole for prevention of pneumocystosis and toxoplasmosis in a dual infection rat model.
    Brun-Pascaud M; Chau F; Rajagopalan-Levasseur P; Derouin F; Girard PM
    J Eukaryot Microbiol; 1996; 43(5):14S-15S. PubMed ID: 8822822
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of atovaquone and atovaquone drug combinations on prophylaxis of Pneumocystis carinii pneumonia in SCID mice.
    Comley JC; Sterling AM
    Antimicrob Agents Chemother; 1995 Apr; 39(4):806-11. PubMed ID: 7785975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
    Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
    N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pneumocystis carinii pneumonia prophylaxis: current therapies and recommendations.
    Crozier F
    J Pediatr Oncol Nurs; 2011; 28(3):179-84. PubMed ID: 21636828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus.
    Simonds RJ; Hughes WT; Feinberg J; Navin TR
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S44-8. PubMed ID: 8547511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of Pneumocystis carinii pneumonia.
    Med Lett Drugs Ther; 1988 Oct; 30(776):94-5. PubMed ID: 3050408
    [No Abstract]   [Full Text] [Related]  

  • 35. Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides.
    Chan C; Montaner J; Lefebvre EA; Morey G; Dohn M; McIvor RA; Scott J; Marina R; Caldwell P
    J Infect Dis; 1999 Aug; 180(2):369-76. PubMed ID: 10395851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators.
    Moorman AC; Von Bargen JC; Palella FJ; Holmberg SD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):182-8. PubMed ID: 9768629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of intravenous pentamidine prophylaxis for Pneumocystis carinii pneumonia.
    Weintrub PS; Wara DW; Duliege AM
    J Pediatr; 1993 Jan; 122(1):163-4. PubMed ID: 8419606
    [No Abstract]   [Full Text] [Related]  

  • 38. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Antinori A; Murri R; Ammassari A; De Luca A; Linzalone A; Cingolani A; Damiano F; Maiuro G; Vecchiet J; Scoppettuolo G
    AIDS; 1995 Dec; 9(12):1343-50. PubMed ID: 8605054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumocystis carinii pneumonia prophylaxis with atovaquone in trimethoprim-sulfamethoxazole-intolerant orthotopic liver transplant patients: a preliminary study.
    Meyers B; Borrego F; Papanicolaou G
    Liver Transpl; 2001 Aug; 7(8):750-1. PubMed ID: 11510024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.
    Hughes W; Leoung G; Kramer F; Bozzette SA; Safrin S; Frame P; Clumeck N; Masur H; Lancaster D; Chan C
    N Engl J Med; 1993 May; 328(21):1521-7. PubMed ID: 8479489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.